Provectus Pharmaceuticals, Inc. Investor files Lawsuit over Executive Pay

An investigation for Provectus Pharmaceuticals, Inc. investors over potential breaches of fiduciary duties by certain directors was announced and current long-term OTC-PVCT stockholders should contact the Shareholders Foundation.
 
 
mail@shareholdersfoundation.com
mail@shareholdersfoundation.com
Feb. 5, 2013 - PRLog -- An investor in shares of Provectus Pharmaceuticals, Inc.  filed a lawsuit against directors of Provectus Pharmaceuticals, Inc. over alleged breaches of fiduciary duties in connection with certain compensation that was awarded to certain executives at Provectus Pharmaceuticals, Inc.

Investors who are current long-term stockholders of shares of Provectus Pharmaceuticals, Inc. , have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554

The plaintiff alleges that Provectus Pharmaceuticals, Inc. awarded over 7 million stock options to four executives in two years, despite the limit of 100,000 per person per year set by the stock plan.

Provectus Pharmaceuticals, Inc.  reported that its Net Loss increased from $18.55 million in 2010 to $19.43 million in 2011.

Shares of Provectus Pharmaceuticals, Inc.  declined from as high as $1.675 per share in March 2010 to as low as $0.52 per share in Nov. 2012.

On Jan. 14, 2013, OTC-PVCT closed at $0.66 per share.

Those who are current long-term stockholders of Provectus Pharmaceuticals, Inc.  shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554
End
Source:
Email:***@shareholdersfoundation.com Email Verified
Phone:+1-(858)-779-1554
Zip:92108
Tags:Provectus Pharmaceuticals, OTC:PVCT, Lawsuit, Executive Pay
Industry:Business, Finance
Location:San Diego - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share